Rectal Lymph Node Metastasis in Recurrent Ovarian Carcinoma: Essential Role of 18F-FDG PET/CT in Treatment Planning

Overview

Journal World J Surg Oncol

Publisher Biomed Central

Specialties General Surgery
Oncology

Date 2013 Aug 14

PMID 23938043

Citations 2

Authors

Koji Kumagai

Terue Okamura

Masao Toyoda

Hideto Senzaki

Chihiro Watanabe

Masahide Ohmichi

Affiliations

Soon will be listed here.

Abstract

Although uncommon, ovarian cancer cells may spread to the rectal lymph nodes. However, few reports have described how to detect and treat such metastases. We report a case of a 59-year-old woman with mesorectal and pararectal lymph node metastases in recurrent ovarian carcinoma, detected conclusively using 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT), and treated by low anterior resection with total mesorectal excision aiming for macroscopic complete resection. The treatment goals for the patient were gradually changed from curative to palliative chemotherapy; she survived for 45 months without rectal obstruction after secondary debulking surgery, and was followed up until autopsy. Thus, 18F-FDG PET/CT may be valuable for detecting rectal lymph node metastasis and can play an essential role in planning treatment for recurrent ovarian carcinoma.

Citing Articles

Clinical Significance of Mesenteric Lymph Node Involvement in the Pattern of Liver Metastasis in Patients with Ovarian Cancer.

Tanaka K, Shimada Y, Nishino K, Yoshihara K, Nakano M, Kameyama H Ann Surg Oncol. 2021; 28(12):7606-7613.

PMID: 33821347 DOI: 10.1245/s10434-021-09899-8.

Avascular Spaces of the Female Pelvis-Clinical Applications in Obstetrics and Gynecology.

Kostov S, Slavchev S, Dzhenkov D, Mitev D, Yordanov A J Clin Med. 2020; 9(5).

PMID: 32414119 PMC: 7291144. DOI: 10.3390/jcm9051460.

References

Prakash P, Cronin C, Blake M . Role of PET/CT in ovarian cancer. AJR Am J Roentgenol. 2010; 194(6):W464-70. DOI: 10.2214/AJR.09.3843. View

Galandiuk S, Chaturvedi K, Topor B . Rectal cancer: a compartmental disease. the mesorectum and mesorectal lymph nodes. Recent Results Cancer Res. 2005; 165:21-9. DOI: 10.1007/3-540-27449-9_4. View

Schillaci O . Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity. Semin Nucl Med. 2012; 42(4):267-80. DOI: 10.1053/j.semnuclmed.2012.02.003. View

Baiocchi G, Cestari L, Macedo M, Oliveira R, Fukazawa E, Faloppa C . Surgical implications of mesenteric lymph node metastasis from advanced ovarian cancer after bowel resection. J Surg Oncol. 2011; 104(3):250-4. DOI: 10.1002/jso.21940. View

McMahon C, Rofsky N, Pedrosa I . Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging. Radiology. 2009; 254(1):31-46. DOI: 10.1148/radiol.2541090361. View

Salani R, Diaz-Montes T, Giuntoli R, Bristow R . Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma. Ann Surg Oncol. 2007; 14(12):3552-7. DOI: 10.1245/s10434-007-9565-7. View

Manci N, Bellati F, Graziano M, Pernice M, Muzii L, Angioli R . Ovarian cancer, diagnosed with PET, with bilateral inguinal lymphadenopathy as primary presenting sign. Gynecol Oncol. 2005; 100(3):621-2. DOI: 10.1016/j.ygyno.2005.09.026. View

Chi D, McCaughty K, Diaz J, Huh J, Schwabenbauer S, Hummer A . Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer. 2006; 106(9):1933-9. DOI: 10.1002/cncr.21845. View

Park J, Seo S, Kang S, Lee K, Lim S, Choi H . The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns. Gynecol Oncol. 2006; 103(3):977-84. DOI: 10.1016/j.ygyno.2006.06.004. View

10.

Guth U, Huang D, Bauer G, Stieger M, Wight E, Singer G . Metastatic patterns at autopsy in patients with ovarian carcinoma. Cancer. 2007; 110(6):1272-80. DOI: 10.1002/cncr.22919. View

11.

Chan W, Ramsay S, Szeto E, Freund J, Pohlen J, Tarlinton L . Dual-time-point (18)F-FDG-PET/CT imaging in the assessment of suspected malignancy. J Med Imaging Radiat Oncol. 2011; 55(4):379-90. DOI: 10.1111/j.1754-9485.2011.02287.x. View

12.

Susini T, Olivieri S, Molino C, Castiglione F, Tavella K, Viligiardi R . Ovarian cancer initially presenting as intramammary metastases and mimicking a primary breast carcinoma: a case report and literature review. J Womens Health (Larchmt). 2010; 19(1):169-74. DOI: 10.1089/jwh.2009.1465. View

13.

Lenhard M, Burges A, Johnson T, Stieber P, Kumper C, Ditsch N . PET-CT in recurrent ovarian cancer: impact on treatment planning. Anticancer Res. 2008; 28(4C):2303-8. View